Modification of Complications Caused by Polycystic Ovary Syndrome by Nano Curcumin Drug and HIIT Exercise in Women Undergoing ICSI Treatment
Phase 3
Recruiting
- Conditions
- E28.2Polycystic ovary syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT20210207050279N1
- Lead Sponsor
- Iranian academic center for education culture and research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Period Disorders
Hirsutism
Infertility
Increased LH/FSH ratio
Ultrasound View in the form of Enlarged Ovaries
Having Numerous Follicles with a Size of 2-10 mm
The Normality of Sperm Analysis
Normal Thyroid Function
No Endometriosis
Normal Prolactin Level
Normal Hysterosalpingography
Exclusion Criteria
Infertility Factors other than Ovulation
Male factor infertility
Pelvic Organ Injuries
Congenital Adrenal Hyperplasia
Thyroid Dysfunction
Cushing Syndrome
Severe Liver or Kidney Diseases
Active Gastric Ulcer
Drug Sensitivity
Intolerance of Exercise
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Regulation of Sex Hormones. Timepoint: Before Taking the Drug and 12 weeks After Starting to Take the Drug. Method of measurement: Elisa Kit.;Stress Oxidative Level. Timepoint: Before Taking the Drug and 12 weeks After Starting to Take the Drug. Method of measurement: Laboratory Kits.;Oocyte and Embryo Quality. Timepoint: After Completing the Intervention. Method of measurement: Shape and Morphology.
- Secondary Outcome Measures
Name Time Method Pregnancy Rate. Timepoint: 2 Weeks After Embryo Transfer. Method of measurement: Laboratory kits.